Reports › Company profiles › UPL Limited
UPL Limited
Latest revenue
INR 39,000 crore
FY2024 · YoY: -5%
Employees
~13,000
Sector: Agrochemicals — Crop Protection & Seeds | HQ: Mumbai, Maharashtra | Founded: 1969 | Employees: ~21,000
Listed as: NSE / BSE listed (UPL.NS) | NSE / BSE | Ticker: UPL.NS | Website →
Live stock price (NSE)
₹642
-3.60 (-0.56%) today
Source: Yahoo Finance · Refreshed every 15 minutes · Fetched 2/6/2026, 11:34:17 pm IST. For information only; not investment advice.
Company overview
UPL Limited is a global agrochemical company headquartered in Mumbai, India, and one of the largest Indian crop protection companies by revenue. The company manufactures and markets a broad portfolio of agrochemical formulations including herbicides, insecticides, fungicides, and plant growth regulators under brands such as 'Super Gro' and 'UPL Crop Protection'. Following the 2019 acquisition of Arysta LifeScience, UPL became the fifth-largest agrochemical company globally by revenue, serving farmers in over 130 countries.
Recent developments
February - May 2026UPL announced a major group restructuring in February 2026, spinning off its crop protection arm into a separate listed entity. This move will create the world's second-largest listed pure-play crop protection platform [6][7][9][10]. The company positioned this as a strategic move to unlock value and sharpen focus on its core agrochemicals business, aligning with its manufacturing operations at the pesticide plant [2]. The announcement triggered significant market volatility: UPL shares tumbled 12-14% on February 23, reflecting investor concerns about the reorganisation plan and its near-term implications [3][5].
In May 2026, UPL released its Q4 results alongside other major corporates [8], while also adapting its portfolio to India's evolving crop shift patterns, navigating both new risks and opportunities in the domestic agrochemical market [4]. The restructuring remains a key development for stakeholders assessing the long-term trajectory of UPL's manufacturing and crop protection platform.
Sources (9)
- UPL to create world’s second largest listed pure-play crop protection platform - Indian Chemical News · Indian Chemical News · Sat, 21 Feb 2026
- UPL share price tanks 14% following the company's reorganisation plan; finer details and what analysts said - Upstox · Upstox · Mon, 23 Feb 2026
- UPL Adapts to India's Crop Shift: New Risks and Rewards Emerge - Whalesbook · Whalesbook · Sat, 09 May 2026
- UPL share price tumbles 12%: Why is the stock falling today? - India Today · India Today · Mon, 23 Feb 2026
- UPL to spin off crop protection arm into a separate listed entity - The Economic Times · The Economic Times · Fri, 20 Feb 2026
- UPL Plans Major Restructuring to Form World’s Second-Largest Crop Protection Company - Global Agriculture · Global Agriculture · Fri, 20 Feb 2026
- Q4 results: JSW Energy, PVR Inox, Canara Bank, UPL, and 64 more on May 11 - Business Standard · Business Standard · Mon, 11 May 2026
- UPL announces group rejig to create world’s 2nd-largest listed pure-play crop protection firm - Mint · Mint · Fri, 20 Feb 2026
- UPL Creates World’s Second Largest Listed Pure-Play Crop Protection Platform - AgriBusiness Global · AgriBusiness Global · Fri, 20 Feb 2026
Financial performance and recent trajectory
Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.
12-month price trajectory
Monthly closes over the last 12 months. Source: Yahoo Finance.
Competitive position
UPL competes globally with multinationals including BASF SE, Syngenta Group, Bayer CropScience, FMC Corporation, and Corteva Inc.; regionally in India it competes with Insecticides India, Tata Chemicals, and Gujarat State Fertilizers. UPL differentiates through its integrated 'OpenAg' platform offering end-to-end crop solutions and its strong presence in generic agrochemical formulations.
Key risks
Regulatory risks including pesticide bans and stricter environmental norms in key markets Currency fluctuation exposure from significant international revenue across multiple geographies Raw material price volatility for key intermediates used in agrochemical production Intense competition from generic manufacturers and consolidation among global multinationals
Outlook
UPL is a participant in the Indian agrochemicals / pesticides plant category, which forms part of the broader Manufacturing space. The Indian agrochemicals / pesticides plant market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For UPL specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for UPL mirrors the broader agrochemicals / pesticides plant category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for UPL as a peer benchmark within the agrochemicals / pesticides plant category. For investors, lenders, or new entrant promoters seeking a fuller assessment of UPL, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.
KAMRIT point of view
Building or competing with UPL?
KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the agrochemicals — crop protection & seeds sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of UPL and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.
Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.